Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial tags : Trials save search
SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR's SyMRI NEURO Software at SimonMed Facilities
Published: 2024-04-17 (Crawled : 09:00) - prnewswire.com
PHG | $19.98 -0.84% 0.0% 500K
|
Health Technology
|
| O: -2.01%
H: 1.0%
C: 0.7%
software expansion trials
Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.64%
H: 0.45%
C: -0.04%
million series trials program
Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
RVPH | $3.03 -5.31% -5.61% 120K
|
|
| O: -7.05%
H: 4.96%
C: 1.46%
fda brilaroxazine trials for schizophrenia
Kraig Biocraft Laboratories Announces Successful Launch of Spring Production Trials in Southeast Asia for Spider Silk
Published: 2024-04-15 (Crawled : 11:00) - globenewswire.com
KBLB | $0.0854 -0.63% 330K
|
Mining, Quarrying, and Oil and ...
|
| O: 3.95%
H: 8.77%
C: 0.76%
trials spring for asia
Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency
Published: 2024-04-08 (Crawled : 11:00) - globenewswire.com
INZY | $4.57 -1.72% -1.75% 560K
|
Health Technology
|
| O: 2.2%
H: 7.69%
C: -9.69%
inz-701 pharma positive ongoing trials topline
Contineum Dials Back Plans with $110M IPO to Fund Neuroinflammatory Trials
Published: 2024-04-05 (Crawled : 14:30) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
neuroinflammatory back trials
Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
NTRA S | $87.19 -3.48% -3.6% 1.1M
|
Health Services
|
| O: -0.6%
H: 2.8%
C: 2.25%
cancer trials trial
Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Published: 2024-03-27 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
MRNA S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: 2.02%
H: 1.41%
C: 0.92%
vaccine trials
Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024
Published: 2024-03-26 (Crawled : 12:30) - globenewswire.com
INZY | $4.57 -1.72% -1.75% 560K
|
Health Technology
|
| O: 2.09%
H: 14.47%
C: 6.6%
inz-701 pharma report ongoing trials topline
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
Published: 2024-03-25 (Crawled : 13:00) - globenewswire.com
SAVA | $21.18 -0.42% -0.42% 970K
|
Health Technology
|
| O: 3.43%
H: 2.0%
C: -3.86%
review trials sciences
Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials
Published: 2024-03-20 (Crawled : 11:00) - prnewswire.com
LH M | $199.45 -0.26% 0.27% 770K
|
Health Services
|
| O: -0.32%
H: 0.29%
C: -0.45%
disease test biomarker blood trials alzheimer's
Kraig Biocraft Laboratories Brings Leading Sericulture Expert from India for Launch of Spring Production Trials
Published: 2024-03-19 (Crawled : 11:00) - globenewswire.com
KBLB | $0.0854 -0.63% 330K
|
Mining, Quarrying, and Oil and ...
|
| O: 0.0%
H: 9.41%
C: 2.83%
india trials spring
Clinical Trials Market Size and Global Forecast Report 2024: Industry Trends, Share, Growth, Insight, Company Analysis 2023-2030
Published: 2024-03-13 (Crawled : 15:30) - prnewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ICLR | $291.74 -0.1% -0.1% 500K
|
Health Technology
|
| O: 0.61%
H: 0.16%
C: -2.04%
company report trials global market
Merck Announces Plans to Conduct Clinical Trials of a Novel Investigational Multi-Valent Human Papillomavirus (HPV) Vaccine and Single-Dose Regimen for GARDASIL®9
Published: 2024-03-13 (Crawled : 11:00) - biospace.com/
MRK | $125.23 -0.11% 0.0% 6M
|
Health Technology
|
| O: 0.41%
H: 0.04%
C: -0.81%
gardasil vaccine merck trials
Global Bispecific Antibody Market Clinical Trials Insight Report to 2029: 12 Bispecific Antibodies Generated Revenue of Over US$ 8.5 Billion in 2023
Published: 2024-03-13 (Crawled : 03:00) - prnewswire.com
IMAB | $1.795 -0.83% -0.84% 140K
|
Health Technology
|
| O: 3.28%
H: 2.65%
C: -2.65%
report antibody revenue trials global market
Kraig Biocraft Laboratories Senior Management travels to Vietnam for Launch of Spring Trials
Published: 2024-03-12 (Crawled : 11:00) - globenewswire.com
KBLB | $0.0854 -0.63% 330K
|
Mining, Quarrying, and Oil and ...
|
| O: 3.02%
H: 8.1%
C: -12.2%
management trials spring
Asha Therapeutics to Present at AD/PD™ 2024 International Conference and Announces Clinical Development Plan for Lead Programs Anticipated to Enter Clinical Trials this Year and Welcomes Two New SAB Members
Published: 2024-03-08 (Crawled : 15:30) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
conference year international trials therapeutics
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
Published: 2024-03-07 (Crawled : 11:00) - globenewswire.com
IMRN | $2.41 -9.28% 9.6K
|
Health Technology
|
| O: 104.23%
H: 76.85%
C: 35.01%
travelan positive trials results
Clinical trials market size in US to grow by USD 5.9 billion from 2022 to 2027, The rise in the number of clinical trials of drugs is the key factor driving market growth, Technavio
Published: 2024-03-06 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.0%
H: 0.8%
C: 0.8%
TMO | News | $541.52 -1.05% 0.61% 2.1M
|
Health Technology
|
| O: 0.64%
H: 1.7%
C: 0.54%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.2%
H: 0.71%
C: 0.33%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
ICLR | $291.74 -0.1% -0.1% 500K
|
Health Technology
|
| O: 2.54%
H: 0.22%
C: -2.44%
trials key market
HII Completes Acceptance Trials on Richard M. McCool Jr. (LPD 29)
Published: 2024-03-04 (Crawled : 13:30) - globenewswire.com
HII | $268.84 -0.88% -0.68% 270K
|
Electronic Technology
|
| O: 0.04%
H: 1.91%
C: 1.31%
trials
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.